Recruiting studies: Cftr Gene Mutation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Phase 2 · 13 location(s) · Arcturus Therapeutics, Inc. · NCT06747858 Cystic Fibrosis in the Kidney: Monitoring the Effectiveness of Elexacaftor/tezacaftor/ivacaftor in Urine After a Short P
NA · 1 location(s) · University of Aarhus · NCT05818319 Rare CFTR Mutation Cell Collection Protocol (RARE)
Phase N/A · 1 location(s) · George Solomon · NCT03161808 Correction of Nonsense Mutations in Cystic Fibrosis
Phase N/A · 8 location(s) · University Hospital, Lille · NCT03670472

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.